Polymalic acid nanobioconjugate for simultaneous inhibition of tumor growth and immunostimulation in HER2/neu-positive breast cancer

Breast cancer remains the second leading cause of cancer death among women in the United States. The breast cancer prognosis is particularly poor in case of tumors overexpressing the oncoprotein HER2/neu. A new nanobioconjugate of the Polycefin family of anti-cancer drugs based on biodegradable and...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Ding, Hui, Helguera, Gustavo, Rodríguez, José A., Markman, Janet, Luria-Pérez, Rosendo, Gangalum, Pallavi, Portilla-Arias, Jose, Inoue, Satoshi, Daniels-Wells, Tracy R., Black, Keith, Holler, Eggehard, Penichet, Manuel L., Ljubimova, Julia Y.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3971991/
https://ncbi.nlm.nih.gov/pubmed/23770212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2013.06.001
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items